載入中
Neuphoria Therapeutics, Inc. is a biotechnology company currently advancing treatments through clinical trials. Its core mission involves pioneering therapies specifically engineered to address the intricate requirements of individuals living with neuropsychiatric disorders. The company was established on December 23, 2024, and its main corporate offices are located in Burlington, Massachusetts.
前收盤價
US$3.36
+US$0.01 · +0.30%
盤中時間採用ET。市場資料可能有所延遲。
Neuphoria Therapeutics, Inc. is a biotechnology company currently advancing treatments through clinical trials. Its core mission involves pioneering therapies specifically engineered to address the intricate requirements of individuals living with neuropsychiatric disorders. The company was established on December 23, 2024, and its main corporate offices are located in Burlington, Massachusetts.
日內區間
目前US$3.36
52週區間
目前US$3.36
盤中時間採用ET。市場資料可能有所延遲。
Neuphoria Therapeutics, Inc. is a biotechnology company currently advancing treatments through clinical trials. Its core mission involves pioneering therapies specifically engineered to address the intricate requirements of individuals living with neuropsychiatric disorders. The company was established on December 23, 2024, and its main corporate offices are located in Burlington, Massachusetts.
日內區間
目前US$3.36
52週區間
目前US$3.36
獲利能力占已公布營收的百分比。
營收
營業利益
淨利
| 項目（USD） | 2026會計年度 | 2025會計年度 | 2024會計年度 | 2023會計年度 | 2022會計年度 |
|---|---|---|---|---|---|
| 營收 | 117.42萬 USD | 1564.94萬 USD | — | — | 38.32萬 USD |
| 銷貨成本 | 66.3萬 USD | 66.29萬 USD | 66.3萬 USD | 67.15萬 USD | 1599.9萬 USD |
| 毛利 | 51.12萬 USD | 1498.66萬 USD | −66.3萬 USD | −67.15萬 USD | −997.89萬 USD |
| 研究與開發 | 35.45億 USD | 900.51萬 USD | 1409.94萬 USD | 1967.43萬 USD | 2325.25萬 USD |
| 銷售、一般及管理費用 | 74.39億 USD | 777.34萬 USD | 847.46萬 USD | 1341.24萬 USD | 768.8萬 USD |
| 營業費用 | 1032.17萬 USD | 1611.56萬 USD | 1789.24萬 USD | 3308.67萬 USD | 2374.37萬 USD |
| 利息收入 | 66.56萬 USD | 16.65萬 USD | 22.01萬 USD | 48.64萬 USD | 9867 USD |
| 利息支出 | — | — | — | — | 2.69萬 USD |
| 折舊和攤銷 | 66.3萬 USD | 66.29萬 USD | 66.3萬 USD | 97.07萬 USD | 110.99萬 USD |
| 營業利益 | −981.05萬 USD | −112.91萬 USD | −2678.67萬 USD | −3308.67萬 USD | −3101.72萬 USD |
| 淨利 | −1345.19萬 USD | −36.96萬 USD | −1549.22萬 USD | −3218.17萬 USD | −2293.92萬 USD |
公司資料更新於 2026年10月12日。
| 行動 | 生效日期 | 詳情 | 記錄日期 | 付款日期 |
|---|---|---|---|---|
股票分割 | 2024年12月24日 | 1:12 | — | — |
已生效 2024年12月24日
1:12
報告持有此股票曝險的交易所交易基金。
AI 生成內容及延遲市場資料僅供資訊與教育用途，不構成投資建議。
